✦ LIBER ✦

7004 Final results of a randomized phase II study of OGX-011 (OGX) in combination with docetaxel (DOC)/prednisone versus docetaxel/prednisone in patients with metastatic castration resistant prostate cancer (CRPC)

✍ Scribed by Chi, K.N.; Hotte, S.J.; Yu, E.; Tu, D.; Eigl, B.; Tannock, I.; Saad, F.; North, S.; Powers, J.; Eisenhauer, E.

Book ID: 123440500
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 53 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71382-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CUOG PHASE II RANDOMIZED STUDY OF CUSTIR

CUOG PHASE II RANDOMIZED STUDY OF CUSTIRSEN (OGX-011) COMBINATION THERAPY IN PATIENTS WITH CASTRATE RESISTANT PROSTATE CANCER (CRPC) WHO RELAPSED ON OR WITHIN SIX MONTHS OF 1ST-LINE DOCETAXEL THERAPY

✍ Saad, Fred; Hotte, Sebastien; North, Scott; Eigl, Bernard; Chi, Kim; Czaykowski, 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 57 KB

Phase I study of sorafenib in combinatio

Phase I study of sorafenib in combination with docetaxel and prednisone in chemo-naïve patients with metastatic castration-resistant prostate cancer

✍ Feby Mardjuadi, Jacques Medioni, Joseph Kerger… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 305 KB

4025 POSTER A phase I/II study of suniti

4025 POSTER A phase I/II study of sunitinib in combination with docetaxel (dcx) and prednisone (pdn) in patients with metastatic castrate-resistant prostate cancer (mCRPC)

✍ A. Zurita; N.D. Shore; M.F. Kozloff; C.W. Ryan; T.M. Beer; E. Chow Maneval; I. C 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Randomized phase II study of danusertib

Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failure

✍ Hielke J. Meulenbeld; Jean P. Bleuse; Elio M. Vinci; Eric Raymond; Giordano Vita 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB

A randomized phase II study of cediranib

A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients

✍ Spreafico, Anna; Chi, Kim N.; Sridhar, Srikala S.; Smith, David C.; Carducci, Mi 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 518 KB

Association of Rash With Outcomes in a R

Association of Rash With Outcomes in a Randomized Phase II Trial Evaluating Cetuximab in Combination With Mitoxantrone Plus Prednisone After Docetaxel for Metastatic Castration-resistant Prostate Cancer

✍ Mark T. Fleming; Guru Sonpavde; Michael Kolodziej; Sanjay Awasthi; Thomas E. Hut 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 434 KB